216 related articles for article (PubMed ID: 30622456)
1. Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson's Disease and Diabetes as Well as Potential Therapies?
Vidal-Martinez G; Yang B; Vargas-Medrano J; Perez RG
Front Mol Neurosci; 2018; 11():465. PubMed ID: 30622456
[TBL] [Abstract][Full Text] [Related]
2. FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.
Vidal-Martínez G; Vargas-Medrano J; Gil-Tommee C; Medina D; Garza NT; Yang B; Segura-Ulate I; Dominguez SJ; Perez RG
J Biol Chem; 2016 Sep; 291(39):20811-21. PubMed ID: 27528608
[TBL] [Abstract][Full Text] [Related]
3. FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2+/- Mice.
Vidal-Martinez G; Najera K; Miranda JD; Gil-Tommee C; Yang B; Vargas-Medrano J; Diaz-Pacheco V; Perez RG
Neuroscience; 2019 Jul; 411():1-10. PubMed ID: 31129200
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
Svarcbahs R; Julku UH; Myöhänen TT
J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
[TBL] [Abstract][Full Text] [Related]
5. FTY720 (Fingolimod) reverses α-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells.
Segura-Ulate I; Yang B; Vargas-Medrano J; Perez RG
Neuropharmacology; 2017 May; 117():149-157. PubMed ID: 28153532
[TBL] [Abstract][Full Text] [Related]
6. FTY720-Mitoxy reduces toxicity associated with MSA-like α-synuclein and oxidative stress by increasing trophic factor expression and myelin protein in OLN-93 oligodendroglia cell cultures.
Vargas-Medrano J; Segura-Ulate I; Yang B; Chinnasamy R; Arterburn JB; Perez RG
Neuropharmacology; 2019 Nov; 158():107701. PubMed ID: 31291595
[TBL] [Abstract][Full Text] [Related]
7. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
[TBL] [Abstract][Full Text] [Related]
8. Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays.
Lek S; Vargas-Medrano J; Villanueva E; Marcus B; Godfrey W; Perez RG
J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829427
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection.
Carmo-Gonçalves P; Coelho-Cerqueira E; de Araujo Lima V; Follmer C
Expert Rev Neurother; 2023 Apr; 23(4):321-330. PubMed ID: 37016954
[TBL] [Abstract][Full Text] [Related]
10. Modulation of β-glucocerebrosidase increases α-synuclein secretion and exosome release in mouse models of Parkinson's disease.
Papadopoulos VE; Nikolopoulou G; Antoniadou I; Karachaliou A; Arianoglou G; Emmanouilidou E; Sardi SP; Stefanis L; Vekrellis K
Hum Mol Genet; 2018 May; 27(10):1696-1710. PubMed ID: 29547959
[TBL] [Abstract][Full Text] [Related]
11. Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's disease.
Fang F; Yang W; Florio JB; Rockenstein E; Spencer B; Orain XM; Dong SX; Li H; Chen X; Sung K; Rissman RA; Masliah E; Ding J; Wu C
Sci Rep; 2017 Jun; 7(1):3868. PubMed ID: 28634349
[TBL] [Abstract][Full Text] [Related]
12. Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.
Beatman EL; Massey A; Shives KD; Burrack KS; Chamanian M; Morrison TE; Beckham JD
J Virol; 2015 Dec; 90(6):2767-82. PubMed ID: 26719256
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
[TBL] [Abstract][Full Text] [Related]
14. Novel FTY720-Based Compounds Stimulate Neurotrophin Expression and Phosphatase Activity in Dopaminergic Cells.
Vargas-Medrano J; Krishnamachari S; Villanueva E; Godfrey WH; Lou H; Chinnasamy R; Arterburn JB; Perez RG
ACS Med Chem Lett; 2014 Jul; 5(7):782-6. PubMed ID: 25050165
[TBL] [Abstract][Full Text] [Related]
15. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.
Lima VA; do Nascimento LA; Eliezer D; Follmer C
ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158
[TBL] [Abstract][Full Text] [Related]
16. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.
Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M
J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice.
Cuvelier E; Méquinion M; Leghay C; Sibran W; Stievenard A; Sarchione A; Bonte MA; Vanbesien-Mailliot C; Viltart O; Saitoski K; Caron E; Labarthe A; Comptdaer T; Semaille P; Carrié H; Mutez E; Gressier B; Destée A; Chartier-Harlin MC; Belarbi K
Front Mol Neurosci; 2018; 11():321. PubMed ID: 30333721
[TBL] [Abstract][Full Text] [Related]
18. Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology.
Schaeffer E; Kluge A; Böttner M; Zunke F; Cossais F; Berg D; Arnold P
Front Cell Dev Biol; 2020; 8():573696. PubMed ID: 33015066
[TBL] [Abstract][Full Text] [Related]
19. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
[TBL] [Abstract][Full Text] [Related]
20. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats.
Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P
Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
